Related Experiment Video
Updated: May 23, 2025
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Development of MDM2-Targeting PROTAC for Advancing Bone Regeneration.
Sol Jeong1, Jae-Kook Cha2,3, Wasim Ahmed4
1Department of Oral Microbiology and Immunology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 08826, Republic of Korea.
This study introduces MDM2-PROTACs for bone regeneration, showing potent degradation and biomineralization induction. These novel PROTACs effectively promote bone repair in preclinical models, expanding therapeutic applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Regenerative Medicine
Background:
- Proteolysis-targeting chimeras (PROTACs) are emerging therapeutics that degrade target proteins via the ubiquitin-proteasome system.
- Current PROTAC applications are mainly disease-focused, with limited exploration in regenerative therapies.
Purpose of the Study:
- To develop and evaluate MDM2-targeting PROTACs for enhanced bone regeneration.
- To investigate the efficacy of novel PROTACs in preclinical bone defect and osteoporosis models.
Main Methods:
- Construction of an MDM2-PROTAC library by combining Nutlin-3 and CRBN ligands with diverse linkers.
- Multistep validation including degradation efficiency, biomineralization assays, and whole-transcriptome analysis.
- In vivo assessment in bone graft and ovariectomy (OVX) models for local and systemic administration.
Main Results:
- Developed potent MDM2-PROTACs (CL144, CL174) demonstrating significant biomineralization induction.
- Whole-transcriptome analysis revealed upregulation of key osteogenic marker genes by CL144.
- CL144 effectively promoted bone regeneration in both bone graft and OVX models.
- Combination therapy with CL144 and alendronate showed synergistic effects in the OVX model.
Conclusions:
- MDM2-PROTACs show significant promise for promoting bone regeneration.
- This study represents a novel application of PROTAC technology in regenerative medicine.
- Further development of PROTACs could expand their therapeutic potential in bone repair and related conditions.
More Related Videos
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018